Corrado Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Corrado Advisors’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-667	Closed	-$93K	–	72
2013 Q4	$93K	Buy	+667	New	+$66.7K	0.04%	70

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Corrado Advisors's INO Position: Q1 2014 in Review

Corrado Advisors sold out of Inovio Pharmaceuticals (INO) in Q1 2014, closing a stake of 667 shares — an estimated $93K sold.

Corrado Advisors first reported a position in INO in Q4 2013 and held it in 1 quarter. The position peaked at $93K in Q4 2013. 78 funds tracked by Wall St. Rank hold INO as of Q1 2014.

Corrado Advisors reported no remaining Inovio Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
Corrado Advisors sold 667 Inovio Pharmaceuticals shares in Q1 2014, an estimated $93K.
Corrado Advisors first reported a position in Inovio Pharmaceuticals in Q4 2013 and held it in 1 quarter.
Corrado Advisors's Inovio Pharmaceuticals position peaked at $93K in Q4 2013.
78 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2014.

Based on Corrado Advisors's 13F filing for Q1 2014, filed 7 Apr 2014.